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Abstract Human cathepsin B, the most abundant lysosomal
cysteine protease, has been implicated in a variety of important
physiological and pathological processes. It has been known for a
long time that like other lysosomal cysteine proteases, cathepsin
B becomes inactivated and undergoes irreversible denaturation at
neutral or alkaline pH. However, the mechanism of this
denaturation process remains mostly unknown up to this day.
In the present work, nuclear magnetic resonance spectroscopy
was used to characterize the molecular origin of the neutral-pH
inactivation and the refolding barrier of human cathepsin B. Two
forms of human cathepsin B, the native form with Cys-29 at the
active site and a mutant with Cys-29 replaced by Ala, were shown
to have well-folded structures at the active and slightly acidic
condition of pH 5. Surprisingly, while the native cathepsin B
irreversibly unfolds at pH 7.5, the C29A mutant was found to
maintain a stable three-dimensional structure at neutral pH
conditions. In addition, replacement of Cys-29 by Ala renders the
process of the urea denaturation of human cathepsin B
completely reversible, in contrast to the opposite behavior of
the wild-type cathepsin B. These results are very surprising in
that replacement of one single residue, the active-site Cys-29,
can eliminate the neutral-pH denaturation and the refolding
barrier. We speculate that this finding may have important
implications in understanding the process of pH-triggered
inactivation commonly observed for most lysosomal cysteine
proteases. ß 2000 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Cysteine proteases represent a major component of the ly-
sosomal proteolytic repertoire and play an important role in
intracellular protein degradation [1,2]. Of them, cathepsin B is
the most abundant one which has also been implicated in a
variety of physiological and pathological processes, such as
general intracellular protein turnover [3], bone resorption
[4], cartilage proteoglycan breakdown [5], antigen processing
[6] and the malignant progression of tumors [7]. Like other
papain-like cysteine proteases, cathepsin B is synthesized as an
inactive proenzyme with an N-terminal 62-residue proregion
and a 254-residue protease domain. This proenzyme is e⁄-
ciently sorted to the lysosome and is converted into the sin-
gle-chain form of the mature enzyme by limited proteolysis.
The mature cathepsin B is stable and optimally active at
slightly acidic pH but becomes inactivated under neutral or
slightly alkaline conditions because of irreversible denatura-
tion [8^11]. This neutral-pH inactivation was thought to be
one of the major mechanisms of removing unwanted cysteine
proteases in the extracellular space [2,8,12]. Therefore, func-
tional cathepsin B in the extracellular space needs to be stored
as a non-covalent complex with its own propeptide fragments
[12].
Surprisingly, when returned to the native condition at pH
4^6, the neutral-pH-inactivated cathepsin B was found to
form an inactive and partially folded intermediate isolated
from the active state [8^11]. This observation implies that a
large barrier may exist between the inactivated intermediate
and the active state, therefore raising the possibility that ca-
thepsin B could be one more example that its folding is under
kinetic control, as observed for two well-studied proteases, the
K-lytic protease [13] and subtilisin [14]. In previous studies, it
has been demonstrated that the propeptide of the K-lytic pro-
tease or subtilisin is absolutely required for regeneration of
the active proteases and that the absence of the propeptide
will trap these enzymes in the ‘molten globule’-like, inactive
intermediate state [13,14].
Since the inactivation at neutral pH is common to all lyso-
somal cysteine proteases, understanding of the inactivation
mechanism of cathepsin B will provide a molecular basis to
clarify functions of lysosomal cysteine proteases in vivo and
shed light on the nature of the refolding barrier separating the
native state and the partially folded intermediate. However, in
contrast to extensive biochemical characterizations [1,15], the
structural details of the irreversible inactivation of cathepsin B
have been examined in only a few studies and only by use of
circular dichroism (CD) spectroscopy [8,9]. Therefore, we
have carried out a nuclear magnetic resonance (NMR) study
to explore the molecular mechanism of the neutral-pH inacti-
vation and the refolding barrier which causes the irreversible
inactivation. Our results reveal that replacement of the active-
site Cys-29 can eliminate the irreversible inactivation and the
refolding barrier of human cathepsin B.
2. Materials and methods
2.1. Protein expression
Recombinant and deglycosylated wild-type human cathepsin B, a
mutant of human cathepsin B with Cys-29 replaced by Ala, and rat
cathepsin B with Cys-29 replaced by Ser were expressed in the meth-
ylotrophic yeast Pichia pastoris as K-factor fusion constructs of the
proenzymes in the pPIC9 vector and puri¢ed from the culture super-
natant using procedures published previously [12,16]. The 15N-labelled
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wild-type cathepsin B and the C29A mutant were obtained by grow-
ing the yeast in minimal media BMG and BMM (Invitrogen) with
15NH4SO4 as the sole nitrogen source. Autoprocessing of the wild-
type human cathepsin B occurs during the expression step where the
conditioned medium became acidic as a result of cell growth. The
mature wild-type human cathepsin B was inhibited by adding methyl-
methane thiosulfonate (MMTS) into the supernatant of the cell cul-
ture [17]. The processing of the human procathepsin B mutant was
achieved by incubating the proenzyme ¢rst with catalytic amounts of
the wild-type cathepsin B (V0.5 Wg of active cathepsin B for 1 mg of
the C29A procathepsin B) followed by treatment with agarose-immo-
bilized pepsin. The mature C29A cathepsin B mutant was puri¢ed by
use of a SP-Sepharose column [17]. The C29S rat cathepsin B mutant
was prepared and puri¢ed as described previously [18].
2.2. Preparation of neutral-pH-denatured cathepsin B
The neutral-pH-inactivated sample of the wild-type human cathep-
sin B (MMTS-inhibited form) was prepared by diluting V100 Wl of a
sample of cathepsin B (V0.3 mM, pH 5.0) into 20 ml of 50 mM
phosphate bu¡er at pH 7.5. The diluted cathepsin B was split into
two parts with equal volumes: one was concentrated by centrifugation
to 400 Wl, giving an NMR sample at pH 7.5. The other was kept at
pH 7.5 for 1 h, then the pH was adjusted to pH 5.0 and concentrated
to 400 Wl. The enzymatic activity was monitored by the proteolytic
cleavage of the substrate Z-Phe-Arg-AMC [16]. The NMR samples of
the two mutants (human C29A and rat C29S) at pH 7.5 were pre-
pared following the same protocol at similar protein concentrations.
Active human cathepsin B was generated by adding dithiothreitol
(DTT) to the MMTS-inhibited cathepsin B sample at pH 5 to give
a DTT concentration of 4 mM. Excess MMTS and DTT in the sam-
ple were removed by passing through a Sephadex LH-20 gel ¢ltration
column. The obtained MMTS-free active cathepsin B was diluted to a
very low concentration (V0.4 WM) in the pH 7.5 phosphate bu¡er.
After 1 h at 4‡C, the pH of the sample was adjusted back to 5 and
excess MMTS was added to the sample. The NMR sample was pre-
pared by concentrating the diluted sample of cathepsin B to 400 Wl.
2.3. Preparation of urea-denatured and refolded cathepsin B
Aliquots of 200 Wl of each protein (wild-type and the C29A mutant,
V0.3 mM) were diluted into 40 ml of 50 mM acetate bu¡er at pH 5.0
in the presence of 8.05 M urea. The samples were split into two parts:
one was concentrated to 400 Wl to give an NMR sample in the pres-
ence of 8 M urea, the other was subjected to dialysis against the same
acetate bu¡er without urea. The dialyzed samples were then concen-
trated to 400 Wl.
2.4. NMR experiments
One-dimensional 1H NMR experiments were collected using the
WATERGATE pulse sequence [19] on a Bruker Avance-500 or
Avance-800 NMR spectrometer. Proton two-dimensional Overhauser
e¡ect (NOESY) spectra were acquired at 800 MHz with phase-sensi-
tive detection by time-proportional phase incrementation [20]. 1H-15N
heteronuclear single-quantum correlation (HSQC) spectra were ac-
quired at 500 or 800 MHz using a standard pulse sequence [21].
Spectral processing, display and analysis were performed using the
XwinNMR software package supplied with the spectrometer system.
3. Results and discussion
3.1. Irreversible neutral-pH inactivation of wild-type human
cathepsin B
Native cathepsin B has a well-de¢ned three-dimensional
structure in the crystalline state, as determined by X-ray crys-
tallography [22]. It is also well-folded in solution at a slightly
acidic pH as shown (Fig. 1a) by an HSQC spectrum of the
15N-labeled wild-type human cathepsin B. The HSQC spec-
trum is well-dispersed in both the 1H and 15N dimensions,
with a dispersion of the amide proton and nitrogen resonances
larger than 5 ppm and 30 ppm, respectively. Furthermore, a
large number of crosspeaks are present in the NOESY spec-
Fig. 1. The neutral-pH inactivation of the wild-type human cathepsin B. a: Two-dimensional 1H-15N HSQC spectrum of the MMTS-inhibited
cathepsin B at pH 5 and 298 K. b: One-dimensional 1H NMR spectrum of the MMTS-inhibited cathepsin B at pH 5 and 298 K. c: HSQC
spectrum of the neutral-pH-inactivated cathepsin B at pH 5 and 298 K. d: One-dimensional 1H NMR spectrum of the neutral-pH-inactivated
cathepsin B at pH 5 and 298 K.
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trum of cathepsin B, indicating a tight tertiary packing within
the protein (data not shown). The well-folded and well-packed
properties of the native wild-type cathepsin B can also be
easily visualized by the large chemical shift dispersion in a
one-dimensional 1H NMR spectrum (Fig. 1b). As seen in
Fig. 1b, there are very down¢eld-shifted (at 9.55, 10.48,
11.3, 12.1 and 12.9 ppm) and very up¢eld-shifted proton
resonances. The up¢eld proton resonances at 30.10, 30.4,
31.2 and 31.9 ppm are characteristic of native cathepsin B,
resulting from the tight interior packing of a well-folded en-
zyme.
However, when wild-type cathepsin B was subjected to neu-
tral or slightly alkaline pH, then returned back to pH 5, the
protein failed to refold to the native state. The HSQC spec-
trum (Fig. 1c) of cathepsin B at pH 5, after treatment with pH
7.5, showed greatly reduced resonance dispersions in both
spectral dimensions, i.e. only 1.5 ppm in the 1H dimension
and 23 ppm in the 15N dimension. In parallel, the 1D proton
NMR spectrum (Fig. 1d) became poorly dispersed with the
disappearance of all down¢eld and up¢eld peaks, indicating
clearly that wild-type cathepsin B underwent a large structural
change after being subjected to pH 7.5. This inactive inter-
mediate of the wild-type human cathepsin B is stable at pH 5
for several weeks without any detectable degradation as moni-
tored by electrophoresis, activity assays and NMR spectros-
copy, thus suggesting that there must be a large barrier iso-
lating the partially folded intermediate from the native state.
The same results were obtained with fully active human ca-
thepsin B although only one-dimensional NMR experiments
were done because of the dilute concentration and limited
stability of NMR samples prepared from active cathepsin B
(spectra not shown).
3.2. Molecular determinant of the neutral-pH denaturation
To identify the interactions responsible for the neutral-pH
inactivation, we evaluated the pH dependence of a single mu-
tant of human cathepsin B and a mutant of rat cathepsin B by
use of NMR spectroscopy. The mutant of rat cathepsin B,
with the active-site residue Cys-29 replaced by serine, has
been shown to adopt the same three-dimensional structure
as the wild-type cathepsin B and display speci¢c interactions
with the cathepsin B propeptide and subfragments [18,23].
Although the three-dimensional structure of the C29A mutant
of human cathepsin B is not yet available, this mutant had
similar binding properties to the cathepsin B propeptides as
the C29S rat cathepsin B (unpublished observations). As seen
from Fig. 2a, the 1H-15N HSQC spectrum of 15N-labeled hu-
man cathepsin B (C29A) is as well-dispersed as that of the
wild-type enzyme at pH 5 (Fig. 1a), indicating the lack of
signi¢cant conformational changes induced by the C29A mu-
tation. In addition, the 2D 1H NOESY spectrum of the C29A
mutant of human cathepsin B at pH 5 contains a large num-
ber of NOE crosspeaks which are similar to those for wild-
type human cathepsin B (spectrum not shown), indicating that
the mutant cathepsin B also has a well-folded three-dimen-
sional structure with tight tertiary packing. This tertiary fold-
ing can also be seen from its well-dispersed 1D proton NMR
spectrum at pH 5 (Fig. 2b). The C29A mutant of human
Fig. 2. The absence of the neutral-pH denaturation of the C29A mutant of human cathepsin B. a: Two-dimensional 1H-15N HSQC spectrum
of the C29A mutant of human cathepsin B at pH 5 and 298 K. b: One-dimensional 1H NMR spectrum of the C29A mutant of human cathep-
sin B at pH 5 and 298 K. c: 1H-15N HSQC spectrum of the C29A mutant at pH 7.5 and 298 K. d: One-dimensional 1H NMR spectrum of
the C29A mutant at pH 7.5 and 298 K.
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cathepsin B has a 1D proton spectrum very similar to that of
the wild-type human cathepsin B (Fig. 1b). The proton NMR
spectrum (not shown) of the C29S rat cathepsin B shows only
minor di¡erences from that of the C29A human cathepsin B,
even though almost 20% of the residues in rat cathepsin B are
di¡erent from human cathepsin B [24]. For example, it still
has dramatically down¢eld-shifted and up¢eld-shifted proton
resonances, indicating similar three-dimensional structures of
the mutant human and rat enzymes as can be inferred from
the similar crystal structures of the corresponding active en-
zymes [22,25].
Surprisingly, when the active-site residue Cys-29 was re-
placed, the resulting mutants no longer underwent the process
of the neutral-pH denaturation. As shown in Fig. 2c, the 1H-
15N HSQC spectrum of 15N-labeled human cathepsin B
(C29A) is also well-dispersed at pH 7.5, indicating that no
structural denaturation occurred at this pH. Furthermore,
when the C29A cathepsin B at pH 7.5 was returned to pH
5, the protein produced a 1H-15N HSQC spectrum (not
shown) identical to the original one at pH 5 before the in-
crease of pH (Fig. 2a). The 2D 1H NOESY spectrum of the
C29A mutant at pH 7.5 also contains as many NOE cross-
peaks as at pH 5 (spectra not shown), thus indicating con-
vincingly that the C29A mutant is still well-folded at pH 7.5
with no neutral-pH denaturation occurring. The intactness of
the mutant cathepsin B at pH 7.5 can also be seen in the 1D
proton spectrum at pH 7.5 (Fig. 2d), which is as well dis-
persed as that at pH 5 (Fig. 2b). Similarly, the 1D proton
spectrum of rat C29S at pH 7.5 is almost superimposable
with that at pH 5 (data not shown), again indicating that
no neutral-pH denaturation occurs in the C29S mutant. Fur-
ther experiments indicated that even no denaturation was de-
tected by NMR for the C29A mutant at pH 8.2 (data not
shown). Therefore, it can be concluded that the active-site
residue Cys-29 is responsible for the neutral-pH inactivation
of cathepsin B.
3.3. Origin of the refolding barrier of human cathepsin B
The irreversible denaturation of cathepsin B implies that a
refolding barrier may exist between the native state and the
intermediate. In an attempt to identify the molecular origin of
the refolding barrier of cathepsin B, we compared the unfold-
ing^refolding behavior of human wild-type cathepsin B and
the C29A mutant subjected to chemical denaturants. Since
the C29A mutant cannot be denatured by neutral-pH condi-
tions, we denatured both proteins with 8 M urea, a classic and
strong chemical denaturing condition. As seen in Fig. 3a, the
starting state, the native state of wild-type cathepsin B at pH
5, is well-folded. However, in the presence of 8 M urea, the
protein is severely denatured (Fig. 3b) and gives a poorly
dispersed NMR spectrum. All down¢eld and up¢eld resonan-
ces disappeared, typical of an unfolded protein. Due to the
loss of the chemical shift dispersion of the methyl groups, a
strong and broad peak appears at V0.80 ppm.
The denatured sample of the wild-type cathepsin B was
subjected to refolding by dialysis against 50 mM acetate bu¡er
at pH 5. However, even at a very low concentration (0.1 WM),
protein aggregation was observed and a large amount of pre-
cipitate was formed during refolding. After removing the pre-
cipitate, the obtained NMR sample is so dilute that high-
quality NMR spectra could not be obtained (spectra not
shown). This result is in agreement with the previous ¢nding
Fig. 3. The reversible denaturation with 8 M urea of the C29A mutant of the human cathepsin B. a: One-dimensional 1H NMR spectrum of
the wild-type human cathepsin B at pH 5 and 298 K. b: One-dimensional 1H NMR spectrum of the wild-type human cathepsin B in the pres-
ence of 8 M urea at pH 5 and 298 K. c: One-dimensional 1H NMR spectrum of the C29A mutant at pH 5 and 298 K. d: One-dimensional
1H NMR spectrum of the C29A mutant in the presence of 8 M urea and at pH 5 and 298 K. e: One-dimensional 1H NMR spectrum of the
C29A mutant at pH 5 and 298 K after dialysis to remove urea.
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that any severe denaturation, such as induced by the neutral
pH or urea, was irreversible for the bu¡alo cathepsin B [8].
As seen in Fig. 3c, the proton NMR spectrum of the C29A
mutant of human cathepsin B is also well-dispersed at pH 5.
When 8 M urea was introduced, the 1D spectrum of the C29A
mutant (Fig. 3d) is nearly identical to Fig. 3b, indicating that
like the wild-type protein, the C29A cathepsin B was also
severely unfolded under this condition. Fig. 3e shows the
1D spectrum of the C29A mutant after overnight dialysis to
remove urea. This spectrum is nearly identical to that of the
starting protein, suggesting that the C29A mutant can sponta-
neously and rapidly refold to the native state. It therefore
appears that the critical residue responsible for the refolding
barrier of human cathepsin B is residue Cys-29 which consti-
tutes the Cys-29^His-199 catalytic diad of the active enzyme.
Fig. 4 presents a schematic representation of the three-di-
mensional structure of cathepsin B, with the active-site resi-
dues Cys-29 and His-199 emphasized in a space-¢lling mode.
Both Cys-29 and His-199 are located at the interface between
the two subdomains of cathepsin B. There has been the hy-
pothesis that neutral pH may disrupt a salt bridge between
Cys-29 and His-199 through the deprotonation of the His-199
side chain, resulting in the dissociation of the two subdomains
of cathepsin B and leading to denaturation [9]. Our current
results appear consistent with this hypothesis in that residue
Cys-29 was found to be responsible for the irreversible denat-
uration of cathepsin B. However, the NMR data also imply
that it cannot be the disruption of the Cys-29^His-199 salt
bridge that leads to the neutral-pH denaturation since the
substitution of Cys-29 with Ala in human cathepsin B and
with Ser in rat cathepsin B failed to destroy the three-dimen-
sional structure and the binding activities of cathepsin B. The
irreversible neutral-pH inactivation/denaturation has been ob-
served previously with intact cathepsin B and with Cys-29
blocked by various inhibitors [2,8^11,15], as we report here
with the active enzyme and with Cys-29 blocked through di-
sul¢de bond formation with MMTS. In contrast, the C29A
substitution for human cathepsin B and the C29S substitution
for rat cathepsin B all result in the disappearance of both the
neutral-pH and the irreversible chemical denaturation. We
therefore speculate here that it may be the deprotonation of
His-199 or the loss of a single positive charge alone that leads
to the neutral-pH inactivation/denaturation of cathepsin B.
Indeed, the active-site region of human cathepsin B is ¢lled
with seven negatively charged residues including the active-site
Cys-29, but with only four neutralizing positively charged
residues, including His-199 at low pH [9]. The repulsive neg-
ative charges may be compensated by some positively charged
residues in the prosegment [23,26], a structural feature that
may account for the neutral-pH stability of procathepsin B
and non-covalent cathepsin B^propeptide complexes [12]. The
replacement of Cys-29 with Ala in human cathepsin B and
with Ser in rat cathepsin B eliminates one potentially desta-
bilizing negative charge, or the side-chain ^S3 group, from the
active site and may signi¢cantly alter the side-chain pKa of
His-199, thereby resulting in the disappearance of the neutral-
pH inactivation/denaturation.
In summary, we ¢rst investigated the neutral-pH inactiva-
tion of the wild-type human cathepsin B by use of NMR
spectroscopy and showed that the wild-type human cathepsin
B cannot refold spontaneously to the active state after being
exposed to neutral pH. We then demonstrated that replace-
ment of a single residue, the active-site Cys-29, can eliminate
the neutral-pH inactivation/denaturation and refolding barrier
of cathepsin B. We suggest that our present results may have
direct implications for understanding the neutral-pH inactiva-
tion and irreversible denaturation commonly observed for
most lysosomal cysteine proteases.
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